Forgot Password

Please enter your email below.*
To create your new password, please enter your email address below.
We will send an email with instructions to reset your password.
*It must be the same email you used to register for your account

National Association of Specialty Pharmacy 2019 - Satellite Symposia

National Association of Specialty Pharmacy 2019 - Satellite Symposia

Annual Meeting and Educational Conference

September 9-12, 2019
Washington Mariott Wardman Park
2660 Woodley Rd NW
Washington, DC 20008

Space is limited! Register today to reserve your seat for this CE satellite symposia.



No additional fee is required to attend this CPE-accredited symposium activity; however, registration to the NASP 2019 Annual Meeting and Educational Conference is required.

For more information and to register for the NASP Annual Meeting, please visit: https://www.naspmeeting.com/registration.
Overview
Faculty
Registration
Live Video Stream

Examining the Use of Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy Treatment

Maryland Room • Located on the Lobby Level of Marriott Wardman Park

Monday, September 9, 2019 • 6:00 PM – 7:00 PM – Dinner Session

Description: 
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating and degenerative disease in which peripheral nerve damage results in reduced functioning of the extremities. Approximately 30% of patients with CIDP will become wheelchair dependent. The introduction of subcutaneous immunoglobulin as an option in CIDP treatment has created unique changes to the management of the disease. Specialty pharmacists are in a critical position to facilitate appropriate utilization of immunoglobulin by monitoring dosing, administration schedules, rates, and adverse effects.

Supporter: 
This activity is supported by educational grants from CSL Behring and Grifols.


Examining Interleukin-17– and Interleukin-23–Inhibiting Biologics for Psoriasis and Psoriatic Arthritis Treatment

Maryland Room • Located on the Lobby Level of Marriott Wardman Park

Tuesday, September 10, 2019 • 7:00 AM – 8:00 AM – Breakfast Session

Description: 
Psoriasis is a complex inflammatory skin condition affecting more than 8 million Americans and of these, 10% to 30% will develop psoriatic arthritis affecting the joints. The pathophysiology of illness involves immune dysregulation and uncontrolled activation of proinflammatory cytokines such as TNFα, IL-17, and IL-23. Treatment strategies involve administration of biologics that block these pathways and subsequently reduce systemic inflammation. Specialty pharmacists should be familiar with all the agents used in the management of psoriatic disease and their crucial role in comprehensive patient education and monitoring throughout treatment.

Supporter: 
This activity is supported by an educational grant from AbbVie Inc.


Addressing the Needs of Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Maryland Room • Located on the Lobby Level of Marriott Wardman Park

Tuesday, September 10, 2019 • 12:15 PM – 1:15 PM – Lunch Session

Description: 
Atopic dermatitis is the most common form of eczema affecting the pediatric and adolescent population. This inflammatory skin disorder manifests in skin creases as erythema and dryness with the hallmark symptom being pruritus. The appearance of these skin lesions and subsequent itching can have a significant effect on patients’ quality of life. Treatment is multifaceted and incorporates nonpharmacologic strategies and pharmacologic therapies, including topical, oral, and subcutaneous agents. Specialty pharmacists need to understand the underlying pathophysiology of the disease and be aware of the current treatment landscape to effectively counsel and monitor therapeutic clinical outcomes.

Supporter: 
This activity is supported by educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals.


Examining Treatment Strategies for Myasthenia Gravis: A Specialty Pharmacist’s Review

Maryland Room • Located on the Lobby Level of Marriott Wardman Park

Tuesday, September 10, 2019 • 6:00 PM – 7:00 PM – Dinner Session

Description: 
Myasthenia gravis is a rare autoimmune disease that affects the functionality of the acetylcholine receptor. This disturbance leads to muscle weakness that could affect the eyes, limbs, oropharynx, and diaphragm. A myasthenic crisis is characterized by worsening respiratory function due to weakness of the respiratory muscles, often leading to intubation and in some cases, death. It is likely to be experienced by 15% to 20% of patients with myasthenia gravis. Through this activity, pharmacists will become familiar with myasthenia gravis, its impact on patients, and the current treatment landscape with a focus on specialty medications.

Supporter: 
This activity is supported by educational grants from CSL Behring and Grifols.


Examining the Economic Data Associated With Early Influenza Intervention With Antiviral Therapy

Maryland Room • Located on the Lobby Level of Marriott Wardman Park

Wednesday, September 11, 2019 • 7:00 AM – 8:00 AM – Breakfast Session

Description: 
Influenza is a highly contagious viral illness that affects hundreds of thousands of people annually and causes significant direct and indirect costs to both the health care system and society. Complications related to this virus, especially in high-risk individuals, can result in prolonged hospitalization and death. While the key mode of protection is vaccination, several antivirals exist for prevention and treatment of the illness. Pharmacists should be aware of the medications used in the prevention and treatment of influenza, including their place in therapy, adverse effect profile, and considerations for patient education to provide optimal care.


Examining Treatments and Best Practices for Specialty Pharmacists in the Care of Patients With Amyotrophic Lateral Sclerosis (ALS)

Maryland Room • Located on the Lobby Level of Marriott Wardman Park

Wednesday, September 11, 2019 • 1:30 PM – 2:30 PM – Lunch Session

Description: 
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of motor nerve cells, and with no known cure, its management typically includes an interdisciplinary approach that considers the physical and psychological needs of the patients and their families or caregivers. Since patients have ongoing interaction with pharmacists when filling prescriptions, pharmacists are often in the unique position to regularly monitor the disease and the effects of treatment as well as ensure the continuity of care recommended by the treatment team. The high cost of disease management as well as direct and indirect costs suggest a critical role for pharmacists as the medication experts on ALS care teams who can take a proactive approach to communication to help manage the disease and appropriately set therapy expectations. In addition to pharmacists’ expanding roles in understanding and monitoring symptomatic and disease-modifying therapies in clinic and inpatient settings, the growing number of potential new medications underscores the importance of ongoing education on the management of ALS.

Supporter: 
This activity is supported by an educational grant from Mitsubishi Tanabe Pharma America.



Examining the Use of Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Treatment

Faculty Presenter:

Luigi Brunetti, PharmD, MPH
Associate Professor of Pharmacy
Rutgers, The State University of New Jersey
New Brunswick, New Jersey


Examining Interleukin-17– and Interleukin-23–Inhibiting Biologics for Psoriasis and Psoriatic Arthritis Treatment

Faculty Presenters:

April Jones, PharmD, CSP
Clinical Specialty Pharmacist, Rheumatology
Vanderbilt University Medical Center
Nashville, Tennessee

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE
Associate Professor of Pharmacy Practice
School of Pharmacy
Duquesne University
Pittsburgh, Pennsylvania


Addressing the Needs of Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

Faculty Presenters: 

Steven Scott, PharmD
Associate Professor of Pharmacy Practice
Purdue University College of Pharmacy
West Lafayette, IN

Cari W. Pao, PharmD, MBA, MSHCM
Senior Clinical Director
Walgreens
Deerfield, IL


Examining Treatment Strategies for Myasthenia Gravis: A Specialty Pharmacist’s Review

Faculty Presenter: 

Gil I. Wolfe, MD, FAAN
Irvin and Rosemary Smith Professor and Chairman
Department of Neurology, Jacobs School of Medicine and Biomedical Sciences
University at Buffalo/SUNY
Buffalo, New York


Examining the Economic Data Associated With Early Influenza Intervention With Antiviral Therapy

Faculty Presenter: 

Carrie Koenigsfeld, PharmD, FAPhA
Professor
Drake College of Pharmacy and Health Sciences
Clinical Pharmacist
Unity Point Internal Medicine at Lakeview
Des Moines, Iowa


Examining Treatments and Best Practices for Specialty Pharmacists in the Care of Patients With Amyotrophic Lateral Sclerosis (ALS)

Faculty Presenter: 

Jack J. Chen, PharmD, FASCP, FCCP, BCPS, BCGP
Neurology Pharmacist
Clinical Neurology Consultants
Chino Hills, California


To register for a NASP CE session, a PharmacyTimes account is required. Please create one or if you already have one, sessions are listed below:


Monday, September 9, 2019
Examining the Use of Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy Treatment

register for nasp cidp
 

Tuesday, September 10, 2019
Examining Interleukin-17– and Interleukin-23–Inhibiting Biologics for Psoriasis and Psoriatic Arthritis Treatment

register for nasp psoriasis
 

Tuesday, September 10, 2019
Addressing the Needs of Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

register for nasp atopic
 

Tuesday, September 10, 2019
Examining Treatment Strategies for Myasthenia Gravis: A Specialty Pharmacist’s Review

register for nasp myasthenia gravis
 

Tuesday, September 11, 2019
Examining the Economic Data Associated With Early Influenza Intervention With Antiviral Therapy

register for nasp flu
 

Wednesday, September 11, 2019
Examining Treatments and Best Practices for Specialty Pharmacists in the Care of Patients With Amyotrophic Lateral Sclerosis (ALS)

register for nasp als
 
Not able to attend in person?
We also offering live video streams of the 2019 satellite symposia. Register for the live video streams below:
 

Monday, September 9, 2019
Examining the Use of Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy Treatment

register for nasp cidp live video stream
 

Tuesday, September 10, 2019
Examining Interleukin-17– and Interleukin-23–Inhibiting Biologics for Psoriasis and Psoriatic Arthritis Treatment

register for nasp psoriasis live video stream
 

Tuesday, September 10, 2019
Addressing the Needs of Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

register for nasp atopic live video stream
 

Tuesday, September 10, 2019
Examining Treatment Strategies for Myasthenia Gravis: A Specialty Pharmacist's Review

register for nasp myasthenia gravis live video stream
 

Wednesday, September 11, 2019
Examining Treatments and Best Practices for Specialty Pharmacists in the Care of Patients With Amyotrophic Lateral Sclerosis (ALS)

register for nasp als live video stream
 
SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.